Contact information
Type
Scientific
Primary contact
Mrs Maxine Wedderburn
ORCID ID
Contact details
25 Burlington Ave
Kingston
Kingston 10
Jamaica
+1 876 968 4976
Maxwed@cwjamaica.com
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
Protection of Human Subject Committee, study #9978
Study information
Scientific title
Building bridges from emergency contraceptive to regular contraceptive use in pharmacies: a multicentre participant-randomised unblinded trial
Acronym
Study hypothesis
Can non-users of a regular contraceptive method (a regular contraceptive method for the purposes of this study is defined as either an oral contraceptive pill, an injectable contraceptive method or an intra-uterine devide [IUD]) in Jamaica who intended to purchase an emergency contraceptive product in a pharmacy be encouraged to move toward adopting regular contraception by providing a discount coupon for one cycle of a regular oral contraceptive pill product?
Ethics approval
Family Health International Protection of Human Subjects Committee gave approval on the 28th November 2006 (ref: 9978)
Study design
Multicentre participant-randomised unblinded trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Other
Trial type
Prevention
Patient information sheet
Condition
Family planning
Intervention
The intervention is a discount coupon given to randomly designated clients who arrive at a pharmacy to purchase an emergency contraceptive product.
Intervention type
Other
Phase
Not Applicable
Drug names
Primary outcome measure
Adoption of a regular contraceptive method. Adoption is defined as:
1. Use of oral contraceptive pills for at least two months
2. Receiving one injection of an injectable contraceptive method and either having received a second injection or intending to receive a second injection
3. Use of an IUD for at least one month
Measured at three and six months after participant enrolment (i.e., the pharmacy intercept interview).
Secondary outcome measures
Longest length of continuous use by women who adopt a regular contraceptive method. Measured at three and six months after participant enrolment (i.e., the pharmacy intercept interview).
Overall trial start date
01/12/2006
Overall trial end date
01/02/2008
Reason abandoned (if study stopped)
Eligibility
Participant inclusion criteria
Any woman (aged 16 - 46 years) who arrives at study pharmacy intending to purchase a dedicated emergency contraceptive product.
Participant type
Patient
Age group
Adult
Gender
Female
Target number of participants
800
Participant exclusion criteria
1. Males
2. Women under the age of 16
3. Women currently using a regular contraceptive method (a regular contraceptive method for the purposes of this study is defined as either an oral contraceptive pill, an injectable contraceptive method or an IUD)
Recruitment start date
01/12/2006
Recruitment end date
01/02/2008
Locations
Countries of recruitment
Jamaica
Trial participating centre
25 Burlington Ave
Kingston
Kingston 10
Jamaica
Sponsor information
Organisation
The William and Flora Hewlett Foundation (USA)
Sponsor details
2121 Sand Hill Road
Menlo Park
CA
94025
United States of America
info@hewlett.org
Sponsor type
Charity
Website
Funders
Funder type
Charity
Funder name
The William and Flora Hewlett Foundation (USA)
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Basic results (scientific)
Publication list